Efficacy of a parenteral nutrition mixture in correcting the nutritional status of elderly patients with severe novel coronavirus infection COVID-19

Abstract

In the context of a decrease in the infection of the population with the novel coronavirus infection, as well as a decline in the severity of the course and mortality of COVID-19 patients, the management of patients after the infection remains relevant in the conditions of the so-called «long COVID» (post-COVID syndrome). Currently, the symptom complex of post-COVID syndrome most often includes tiredness, fatigue, pain (myalgia and arthralgia), decreased physical strength and endurance, decreased performance, quality of life, and daily activities. Common mental health problems include anxiety disorders, depression and emotional stress, among other symptoms. Pharmacotherapy of post-COVID syndrome may include anti-inflammatory and analgesic drugs, neurocytoprotectors, antiaggregants and anticoagulants, vitamins, and psychotropic drugs. According to various researchers, fluvoxamine is a drug that can not only have its direct psychotropic effect and be used during the early rehabilitation of patients, but also be considered in the prevention and treatment of the novel coronavirus infection as an antiviral drug, providing anti-inflammatory, antiplatelet and immunomodulatory effects.